BnR Summit 2026

Belt & Road Summit - Deal-Making 2026

9 – 15 Sept 2026 | Hong Kong, China (Hong Kong)

周易生物

nordiabio.com/China (Hong Kong)
17 profile visits

About

Nordia targets on the diabetes with personal or universal islet organoids generated from stem cells through its spontaneous formation of 3D structure of islets. Gene editing and T cell co-culture were used to reduce the immunogenicity. The islet organoids will be transplanted into the patients with biomaterial scaffolds for long-term control of blood glucose levels by steady insulin secretion. Nordia also offers islet-based research services such as drug/target screening.

Areas of activity

Technology

Bio-TechMedical Technology

Urban Development

Technology Park

Additional information

Other Place of Business

Hong KongMainland China

Company Funding Stage

Series A

Terms and Conditions & Disclaimer

I agree

Representatives

生物医药早期项目孵化

周易生物

CTO

周易生物